Name: University of Missouri Research Reactor Center: History, Research, and NextGen Expansion
Address: US

Overview

The University of Missouri Research Reactor Center (MURR) is a nuclear research facility located at the University of Missouri in Columbia, Missouri, United States. The center houses a tank-type nuclear research reactor, which serves as a critical infrastructure asset for scientific inquiry and isotope production. As of June 2025, MURR holds the distinction of being the most powerful university research reactor in the United States, with a thermal output of 10 megawatts. This capacity places it at the forefront of academic nuclear research facilities nationwide, supporting a wide array of experimental and applied science disciplines.

Technical Specifications and Fuel Cycle

The reactor at MURR is fueled with highly enriched uranium, a specific fuel choice that enables the high neutron flux required for advanced research applications. The facility has been operational since its commissioning in 1966, maintaining a long-standing record of continuous service. The University of Missouri serves as the primary operator of the center, managing the daily operations, maintenance, and scientific utilization of the reactor core. The tank-type design is characteristic of many research reactors, where the reactor core is submerged in a large tank of water that serves both as a moderator and a primary coolant, allowing for flexible experimental configurations.

Role in Academic and Scientific Research

MURR’s 10 MW thermal output provides a robust platform for neutron scattering, neutron activation analysis, and the production of medical and industrial isotopes. The facility supports researchers from various departments within the University of Missouri as well as external collaborators from other institutions and industries. The sustained operation since 1966 underscores the reactor's reliability and its integral role in the broader landscape of US nuclear research infrastructure. The use of highly enriched uranium allows for precise control over the neutron flux, which is essential for high-resolution experiments and the efficient production of short-lived isotopes used in medical diagnostics and treatments.

History and Development

The establishment of the University of Missouri Research Reactor Center (MURR) began with strategic planning initiated by the university's leadership. In 1955, Elmer Ellis appointed a feasibility committee to evaluate the potential for a dedicated nuclear research facility on the Columbia campus. This early administrative action laid the groundwork for securing federal approval and defining the technical scope of the project. The committee's work was instrumental in aligning the university's academic goals with the emerging needs of nuclear science research during the mid-20th century.

Following the feasibility studies, the project advanced through regulatory and financial milestones. In 1961, the Atomic Energy Commission granted the necessary permit for the reactor, validating the technical proposals and ensuring compliance with early nuclear safety standards. This approval was a critical step that allowed the university to proceed with site preparation and infrastructure development. The selection of the location was deliberate, utilizing a former polo field on the campus to accommodate the reactor's spatial requirements while minimizing disruption to existing academic buildings.

Construction of the reactor facility commenced in 1963. The building phase involved erecting the tank-type reactor structure and integrating the necessary support systems for cooling, control, and radiation shielding. The engineering team focused on creating a versatile environment capable of supporting diverse research activities, from neutron activation analysis to isotope production. The construction timeline reflected the urgency of integrating the new facility into the university's research portfolio, with careful attention paid to the integration of the 10 MW thermal output system.

The reactor became operational in 1966, marking the official commissioning of MURR. This launch established the facility as a key asset for the University of Missouri, providing a continuous neutron source for scientific inquiry. The operational start coincided with a period of rapid expansion in nuclear research, allowing MURR to quickly become a hub for interdisciplinary studies. The facility's design, featuring a tank-type reactor fueled by highly enriched uranium, enabled high neutron flux capabilities that supported a wide range of experimental setups.

Decades after its commissioning, the historical significance of MURR was formally recognized. In 2016, the facility received the Nuclear Historic Landmark Award, honoring its contributions to nuclear science and education. This award highlighted the reactor's role in training generations of scientists and engineers, as well as its impact on isotope production for medical and industrial applications. The recognition underscored the enduring value of the 1966 commissioning decision and the sustained operational excellence of the University of Missouri Research Reactor Center.

Why it matters

This capacity distinguishes MURR from other academic facilities, enabling a breadth of scientific inquiry and industrial application that smaller reactors cannot support. The facility operates as a tank-type nuclear research reactor, a design choice that allows for precise control over the neutron flux and efficient cooling, which is critical for maintaining the high thermal output required for diverse research programs.

Medical Isotope Production

A primary function of MURR is the production of medical isotopes, which are essential for diagnostic imaging and radiotherapy. The reactor is a significant source of Iridium-192 (Ir-192), an isotope widely used in brachytherapy for cancer treatment. The high thermal output of 10 megawatts ensures a consistent and high-quality neutron flux, which is necessary for the efficient transmutation of target materials into usable isotopes. This capability supports healthcare systems across the United States by providing a reliable domestic source of critical medical supplies, reducing dependence on international markets and enhancing the stability of the medical isotope supply chain.

Pioneering Neutron Activation Analysis

MURR has played a pioneering role in the development and application of neutron activation analysis (NAA) in forensic science. NAA is a highly sensitive analytical technique that uses the interaction of neutrons with atomic nuclei to determine the elemental composition of a sample. The method is particularly valuable in forensic investigations because it can detect trace elements in evidence such as hair, soil, and glass fragments, often with minimal sample preparation. The reactor’s high neutron flux allows for rapid and accurate analysis, making it a powerful tool for solving criminal cases and advancing forensic methodologies. The formula for the basic neutron capture reaction in NAA can be represented as AX(n,γ)A+1X, where a target nucleus AX captures a neutron n and emits a gamma ray γ to become A+1X.

Comparative Significance

The operational status of MURR as an active facility since its commissioning in 1966 underscores its longevity and adaptability in the face of evolving scientific and technological demands. As the only university-based reactor in the US with a 10 MW thermal output, MURR serves as a unique platform for interdisciplinary research, bridging the gap between academic inquiry and practical application. Its contributions to medical isotope production and forensic science highlight the broader impact of nuclear research infrastructure on public health and justice, demonstrating the value of sustained investment in academic nuclear facilities.

How does MURR support medical research?

The University of Missouri Research Reactor Center (MURR) serves as a critical infrastructure node for global medical isotope production and therapeutic research, leveraging its 10 MW thermal output to generate neutrons for diverse clinical applications (per University of Missouri). The facility’s high neutron flux enables the efficient production of radioisotopes that are often scarce in the global supply chain, directly impacting diagnostic imaging and targeted cancer therapies.

Historical Isotope Production and Therapeutic Development

A landmark achievement in MURR’s medical contribution occurred in 1976 with the production of Iridium-192 (Ir-192) for breast cancer treatment. This isotope became a standard for brachytherapy, where sealed radioactive sources are placed inside or next to the area requiring treatment. The reliability of MURR’s tank-type reactor design allowed for consistent neutron bombardment of iridium targets, ensuring a steady supply of Ir-192, which decays with a half-life of approximately 73.8 days, making it ideal for short-to-medium term therapeutic interventions.

Further advancing oncology, experiments conducted at MURR in 1986 laid the groundwork for the development of QuadraMet and TheraSpheres. These glass microspheres, loaded with the radioisotope Yttrium-90 (Y-90), are used for Selective Internal Radiation Therapy (SIRT) for liver cancer and bone metastases. The process involves irradiating Yttrium-89 targets in the reactor core to produce Y-90, which is then embedded in bioactive glass spheres. These spheres are infused into the hepatic artery, delivering a high dose of beta radiation directly to tumor cells while sparing surrounding healthy tissue. The 1986 experimental data validated the dosimetry and biological efficacy of this approach, leading to widespread clinical adoption.

Boron Neutron Capture Therapy (BNCT)

Current research at MURR focuses heavily on Boron Neutron Capture Therapy (BNCT), a binary, cell-selective radiotherapeutic modality. BNCT relies on the nuclear reaction between a thermal neutron and the Boron-10 isotope (10B). When a thermal neutron is captured by a 10B nucleus, it splits into an alpha particle (4He) and a lithium nucleus (7Li), releasing high linear energy transfer (LET) radiation. The reaction can be expressed as:

10B+nth→7Li+4He+γ+Energy

This reaction occurs within a single cell diameter, allowing for precise targeting of cancer cells that have accumulated boron compounds, such as boronophenylalanine (BPA) or sodium borocaptate (BSA). MURR’s high thermal neutron flux is essential for achieving the required dose rates for effective BNCT. The facility supports preclinical and clinical trials, optimizing boron delivery agents and neutron beam filtering to maximize tumor kill rates while minimizing side effects in surrounding tissues. This ongoing work positions MURR as a leading center for next-generation nuclear medicine, bridging the gap between reactor physics and clinical oncology.

What is the role of the Archaeometry Laboratory?

The Archaeometry Laboratory at the University of Missouri Research Reactor Center (MURR) serves as a specialized analytical hub for material science and historical artifact characterization. Established in 1988, the laboratory has been supported by funding from the National Science Foundation (NSF) (per NSF grant records). Its primary function is to conduct provenance studies, which determine the geographic and geological origins of materials such as ceramics, metals, and glass. By analyzing the elemental composition of these artifacts, researchers can trace trade routes, identify manufacturing techniques, and authenticate historical objects with high precision.

Neutron Activation Analysis

The core analytical technique employed by the laboratory is neutron activation analysis (NAA). This method leverages the high neutron flux available at MURR to irradiate samples, inducing radioactivity in the constituent elements. The resulting gamma-ray spectra allow for the quantification of over 30 distinct elements simultaneously. This multi-element capability is critical for distinguishing between materials that appear visually identical but possess subtle compositional differences. The sensitivity of NAA enables the detection of trace elements, often down to parts per million or even parts per billion, providing a robust chemical fingerprint for each sample.

Complementary Analytical Equipment

In addition to neutron activation analysis, the Archaeometry Laboratory utilizes a suite of complementary instrumental techniques to enhance data resolution. X-ray fluorescence (XRF) is employed for non-destructive elemental analysis, allowing researchers to examine artifacts without altering their physical structure. Inductively coupled plasma mass spectrometry (ICP-MS) provides high-precision measurements of isotopic ratios and trace metal concentrations. The integration of XRF and ICP-MS with NAA creates a multi-dimensional dataset, reducing the margin of error in provenance determinations. This combination of techniques ensures that the laboratory can address a wide range of scientific questions across archaeology, geology, and materials science.

Licensing and Future Plans

The licensing framework for the University of Missouri Research Reactor Center (MURR) has undergone significant modernization to ensure operational continuity and safety. A comprehensive licensing process was initiated in 2006, aiming to update the facility's regulatory standing with the United States Nuclear Regulatory Commission (NRC) and the Missouri State Highway and Transportation Commission. This process involved extensive technical reviews, safety analysis reports, and stakeholder engagements to align the 1966-commissioned tank-type reactor with contemporary nuclear safety standards. The rigorous evaluation confirmed the reactor's robust design and the effectiveness of its operational protocols, paving the way for long-term stability.

License Renewal

In 2017, MURR successfully secured a license renewal, extending its operational authorization until 2037. This renewal was a critical milestone, validating the facility's performance over five decades and securing its status as the most powerful university research reactor in the United States, with a thermal output of 10 megawatts. The renewal process emphasized the reactor's contributions to neutron science, materials testing, and isotope production. It also highlighted the effectiveness of the University of Missouri's operational management and the reactor's fuel cycle, which utilizes highly enriched uranium. The extension to 2037 provides a stable timeline for ongoing research projects and academic programs dependent on MURR's neutron flux.

NextGen MURR Initiative

Looking beyond the 2037 license expiration, the University of Missouri has launched the NextGen MURR initiative. This ambitious project aims to construct a new 20-megawatt research reactor to replace or supplement the existing 10-megawatt unit. The NextGen MURR design incorporates advanced technologies to enhance neutron flux, improve fuel efficiency, and increase operational flexibility. The initiative reflects the growing demand for high-intensity neutron sources in fields such as biology, chemistry, and materials science. By doubling the thermal output, the new reactor is expected to attract more research funding, expand international collaborations, and solidify MURR's leadership in university-based nuclear research. The project involves detailed engineering studies, environmental impact assessments, and stakeholder consultations to ensure a smooth transition and minimal disruption to ongoing research activities.

Worked examples

The University of Missouri Research Reactor Center (MURR) has demonstrated the practical application of neutron activation analysis and isotope production through several landmark case studies. One of the earliest and most notable examples occurred in 1970, when Dr. George Leddicotte utilized MURR’s neutron flux to provide critical courtroom testimony. This case highlighted the transition of neutron activation analysis from a laboratory curiosity to a forensic standard, leveraging the reactor’s ability to trace elemental compositions with high precision.

1970 Forensic Application: Neutron Activation Analysis

In this case study, the objective was to link a suspect to a crime scene using trace elemental evidence. The process followed these steps:

Sample Collection: Hair samples were collected from both the suspect and the victim.
Irradiation: The samples were exposed to the neutron flux within MURR’s tank-type reactor. The highly enriched uranium fuel provided a stable and intense neutron source, essential for activating the trace elements within the hair.
Gamma Spectroscopy: After irradiation, the gamma rays emitted by the activated isotopes were measured. This allowed Dr. Leddicotte to determine the precise concentration of elements such as sodium, magnesium, and potassium in each sample.
Comparative Analysis: The elemental "fingerprint" of the suspect’s hair was compared to the victim’s. The statistical match provided compelling evidence in the courtroom, demonstrating the power of MURR’s 10 MW thermal output in forensic science.

1986 Medical Isotope Development: Cancer Treatments

A second major case study involves the development of FDA-approved cancer treatments, originating from experiments conducted in 1986. This example illustrates MURR’s role in medical isotope production:

Target Selection: Researchers selected specific target materials to be irradiated, aiming to produce radioisotopes with optimal half-lives and decay properties for cancer therapy.
Reactor Irradiation: The targets were placed in the reactor core, where they were bombarded by neutrons. The high thermal output of 10 MW ensured a high production rate of the desired isotopes.
Purification and Testing: The irradiated targets were removed and chemically purified to isolate the specific radioisotopes. Rigorous testing was conducted to verify their purity and efficacy.
FDA Approval: The resulting isotopes were integrated into cancer treatment protocols. The success of the 1986 experiments led to FDA approval, marking a significant milestone in the use of university-based research reactors for medical advancements.

These examples underscore MURR’s dual impact on forensic science and medicine, leveraging its operational status and 10 MW capacity to drive innovation since its commissioning in 1966.

References

#Medical Isotopes #Nuclear Research #University of Missouri #Neutron Activation Analysis #Archaeometry